{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:43:41Z","timestamp":1790790221565,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>Background and Aims<\/jats:title>\n            <jats:p>The clinical utility of two biomarkers, hepatitis B virus (HBV) RNA and hepatitis B core\u2010related antigen (HBcrAg), as compared to conventional markers of HBV replication and disease activity, is unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Approach and Results<\/jats:title>\n            <jats:p>Untreated participants in the North American Hepatitis B Research Network Adult Cohort Study were categorized by chronic hepatitis B (CHB) phases based on HBsAg and HBeAg status and HBV DNA and alanine aminotransferase (ALT) levels. HBV RNA and HBcrAg were measured (Abbott HBV pgRNA Research Assay and Fujirebio Lumipulse Immunoassay, respectively), and cross\u2010sectional associations with conventional CHB markers were tested. Among 1,409 participants across all CHB phases, median HBV DNA was 3.8 log<jats:sub>10<\/jats:sub> IU\/mL and ALT was 34\u00a0U\/L. HBV RNA was quantifiable in 99% of HBeAg<jats:sup>+<\/jats:sup> and 58% of HBeAg<jats:sup>\u2212<\/jats:sup> participants; HBcrAg was quantifiable in 20% of HBeAg<jats:sup>+<\/jats:sup> (above linear range in the other 80%) and 51% of HBeAg<jats:sup>\u2212<\/jats:sup> participants. Both markers differed across CHB phases (<jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0&lt;\u00a00.001), with higher levels in the HBeAg<jats:sup>+<\/jats:sup> and HBeAg<jats:sup>\u2212<\/jats:sup> immune active phases. HBV RNA and HBcrAg correlated moderately strongly with HBV DNA in both HBeAg<jats:sup>+<\/jats:sup> and HBeAg<jats:sup>\u2212<\/jats:sup> phases (HBV RNA: e<jats:sup>+<\/jats:sup> \u03c1\u00a0=\u00a00.84; e<jats:sup>\u2212<\/jats:sup> \u03c1\u00a0=\u00a00.78; HBcrAg: e<jats:sup>+<\/jats:sup> \u03c1\u00a0=\u00a00.66; e<jats:sup>\u2212<\/jats:sup> \u03c1\u00a0=\u00a00.56; <jats:italic toggle=\"yes\">P<\/jats:italic> for all, &lt;0.001), but with HBsAg levels among HBeAg<jats:sup>+<\/jats:sup> phases only (HBV RNA: e<jats:sup>+<\/jats:sup> \u03c1\u00a0=\u00a00.71; <jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0&lt;\u00a00.001; e<jats:sup>\u2212<\/jats:sup> \u03c1\u00a0=\u00a00.18; <jats:italic toggle=\"yes\">P\u00a0<\/jats:italic>=\u00a00.56; HBcrAg: e<jats:sup>+<\/jats:sup> \u03c1\u00a0=\u00a00.51; <jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0&lt;\u00a00.001; e<jats:sup>\u2212<\/jats:sup> \u03c1\u00a0=\u00a00.27; <jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0&lt;\u00a00.001). Associations of higher HBV RNA and HBcrAg levels with higher ALT, APRI, and Fibrosis\u20104 levels were consistent in HBeAg<jats:sup>\u2212<\/jats:sup>, but not HBeAg<jats:sup>+<\/jats:sup>, phases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Despite clear relationships between HBV RNA and HBcrAg levels and CHB phases, these markers have limited additional value in differentiating CHB phases because of their strong association with HBV DNA and, to a lesser extent, with clinical disease indicators.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.32018","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T14:33:24Z","timestamp":1623854004000},"page":"2395-2409","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":67,"title":["Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America"],"prefix":"10.1097","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2837-0188","authenticated-orcid":false,"given":"Marc G.","family":"Ghany","sequence":"first","affiliation":[{"name":"Liver Diseases Branch,NIDDK,NIH,Bethesda,MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy C.","family":"King","sequence":"additional","affiliation":[{"name":"Graduate School of Public Health University of Pittsburgh,Pittsburgh,PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Lisker\u2010Melman","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine and John Cochran VA Medical Center,St. Louis,MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.F.","family":"Lok","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,University of Michigan,Ann Arbor,MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4143-1950","authenticated-orcid":false,"given":"Norah","family":"Terrault","sequence":"additional","affiliation":[{"name":"Division of Gastrointestinal and Liver Diseases,Keck Medicine of University of Southern California,Los Angeles,CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry L.A.","family":"Janssen","sequence":"additional","affiliation":[{"name":"Toronto Centre for Liver Disease,University of Toronto,Toronto,ON,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9178-9139","authenticated-orcid":false,"given":"Mandana","family":"Khalili","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Department of Medicine,University of California San Francisco,San Francisco,CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond T.","family":"Chung","sequence":"additional","affiliation":[{"name":"Hepatology and Liver Center,Massachusetts General Hospital,Boston,MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Lee","sequence":"additional","affiliation":[{"name":"Meredith Mosle Chair in Liver Disease,UT Southwestern Medical Center,Dallas,TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4139-1987","authenticated-orcid":false,"given":"Daryl T.Y.","family":"Lau","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Beth Israel Deaconess Medical Center,Harvard Medical School,Boston,MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin A.","family":"Cloherty","sequence":"additional","affiliation":[{"name":"Abbott Diagnostics,Abbott Park,IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8637-2475","authenticated-orcid":false,"given":"Richard K.","family":"Sterling","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition,Virginia Commonwealth University,Richmond,VA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"hep32018-bib-0001-20250824","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"hep32018-bib-0002-20250824","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jvh.12643","article-title":"Determination of hepatitis B phenotype using biochemical and serological markers","volume":"24","year":"2017","journal-title":"J Viral Hepat"},{"key":"hep32018-bib-0003-20250824","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.gastro.2018.11.037","article-title":"New and old biomarkers for diagnosis and management of chronic hepatitis b virus infection","volume":"156","year":"2019","journal-title":"Gastroenterology"},{"key":"hep32018-bib-0004-20250824","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1128\/JCM.00366-07","article-title":"Hepatitis B virus core\u2010related antigens as markers for monitoring chronic hepatitis B infection","volume":"45","year":"2007","journal-title":"J Clin Microbiol"},{"key":"hep32018-bib-0005-20250824","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/liv.13346","article-title":"Hepatitis B virus core\u2010related antigen as a surrogate marker for covalently closed circular DNA","volume":"37","year":"2017","journal-title":"Liver Int"},{"key":"hep32018-bib-0006-20250824","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jhep.2016.09.028","article-title":"Serum HBV pgRNA as a clinical marker for cccDNA activity","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"hep32018-bib-0007-20250824","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41598-017-00111-0","article-title":"Serum hepatitis B core\u2010related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"hep32018-bib-0008-20250824","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hep.27381","article-title":"Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors","volume":"61","year":"2015","journal-title":"Hepatology"},{"key":"hep32018-bib-0009-20250824","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cmi.2017.03.003","article-title":"Serum hepatitis B core\u2010related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype","volume":"23","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"hep32018-bib-0010-20250824","first-page":"e601","article-title":"Hepatitis B core\u2010related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D","volume":"21","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"hep32018-bib-0011-20250824","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2016.05.029","article-title":"Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"hep32018-bib-0012-20250824","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/hep.30325","article-title":"Serum hepatitis B virus RNA: a new potential biomarker for chronic hepatitis B virus infection","volume":"69","year":"2019","journal-title":"Hepatology"},{"key":"hep32018-bib-0013-20250824","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/apt.14376","article-title":"Review article: hepatitis B core\u2010related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection","volume":"47","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"hep32018-bib-0014-20250824","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jhep.2018.11.030","article-title":"Serum hepatitis B core\u2010related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"hep32018-bib-0015-20250824","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12876-019-0966-4","article-title":"Serum HBV\u2010RNA quantification: useful for monitoring natural history of chronic hepatitis B infection","volume":"19","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"hep32018-bib-0016-20250824","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/jvh.12908","article-title":"Natural history of serum HBV\u2010RNA in chronic HBV infection","volume":"25","year":"2018","journal-title":"J Viral Hepat"},{"key":"hep32018-bib-0017-20250824","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/hep.31616","article-title":"HBV\u2010RNA profiles in chronic hepatitis B patients under different disease phases and anti\u2010viral therapy","volume":"73","year":"2021","journal-title":"Hepatology"},{"key":"hep32018-bib-0018-20250824","first-page":"1063","article-title":"Predictive value of hepatitis B core\u2010related antigen (HBcrAg) during the natural history of hepatitis B virus infection","volume":"63","year":"2017","journal-title":"Clin Lab"},{"key":"hep32018-bib-0019-20250824","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/1469-0691.12739","article-title":"Linearized hepatitis B surface antigen and hepatitis B core\u2010related antigen in the natural history of chronic hepatitis B","volume":"20","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"hep32018-bib-0020-20250824","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cgh.2014.06.028","article-title":"Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype","volume":"13","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32018-bib-0021-20250824","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","year":"2003","journal-title":"Hepatology"},{"key":"hep32018-bib-0022-20250824","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","year":"2006","journal-title":"Hepatology"},{"key":"hep32018-bib-0023-20250824","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1128\/JCM.00813-10","article-title":"Robust hepatitis B virus genotyping by mass spectrometry","volume":"48","year":"2010","journal-title":"J Clin Microbiol"},{"key":"hep32018-bib-0024-20250824","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/hep.30082","article-title":"Hepatitis B virus serum DNA and RNA levels in nucleos(t)ide analog\u2010treated or untreated patients during chronic and acute infection","volume":"68","year":"2018","journal-title":"Hepatology"},{"key":"hep32018-bib-0025-20250824","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12985-018-0994-7","article-title":"High serum levels of pregenomic RNA reflect frequently failing reverse transcription in hepatitis B virus particles","volume":"15","year":"2018","journal-title":"Virol J"},{"key":"hep32018-bib-0026-20250824","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2020.11.003","article-title":"Transition to HBeAg\u2010negative chronic hepatitis B virus infection is associated with reduced cccDNA transcriptional activity","volume":"74","year":"2021","journal-title":"J Hepatol"},{"key":"hep32018-bib-0027-20250824","article-title":"RNAi\u2010based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg","volume":"9","year":"2017","journal-title":"Sci Transl Med"},{"key":"hep32018-bib-0028-20250824","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/hep.29872","article-title":"Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatment","volume":"68","year":"2018","journal-title":"Hepatology"},{"key":"hep32018-bib-0029-20250824","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.3748\/wjg.v25.i32.4764","article-title":"On\u2010treatment monitoring of liver fibrosis with serum hepatitis B core\u2010related antigen in chronic hepatitis B","volume":"25","year":"2019","journal-title":"World J Gastroenterol"},{"key":"hep32018-bib-0030-20250824","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2016.08.009","article-title":"The role of quantitative hepatitis B surface antigen revisited","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"hep32018-bib-0031-20250824","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.cgh.2016.01.019","article-title":"Repeated measurements of hepatitis B surface antigen identify carriers of inactive HBV during long\u2010term follow\u2010up","volume":"14","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32018-bib-0032-20250824","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.gastro.2010.04.052","article-title":"Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers","volume":"139","year":"2010","journal-title":"Gastroenterology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.32018","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.32018","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.32018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T23:08:57Z","timestamp":1756076937000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.32018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.32018","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"2021-02-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}